A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD

NCT06643078 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

487

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: HL231 Solution for Inhalation
DRUG: Ultibro 110μg/50 μg

Sponsor

Haisco Pharmaceutical Group Co., Ltd.

Collaborators

[object Object]